OlympiAD: Further efficacy outcomes in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation receiving olaparib monotherapy vs standard single-agent chemotherapy treatment of physician's choice Meeting Abstract
| Authors: | Delaloge, S.; Conte, P. F.; Im, S. A.; Senkus-Konefka, E.; Xu, B.; Domchek, S. M.; Masuda, N.; Li, W.; Tung, N.; Armstrong, A.; Wu, W.; Goessl, C.; Runswick, S.; Robson, M. |
| Abstract Title: | OlympiAD: Further efficacy outcomes in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation receiving olaparib monotherapy vs standard single-agent chemotherapy treatment of physician's choice |
| Meeting Title: | 42nd ESMO Congress (ESMO 2017) |
| Journal Title: | Annals of Oncology |
| Volume: | 28 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2017 Sep 8-12 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2017-09-01 |
| Start Page: | mdx365.006 |
| Language: | English |
| ACCESSION: | WOS:000411324000232 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdx365.006 |
| Notes: | Meeting Abstract: 243PD -- Appears on page 77 of the abstract book -- Source: Wos |
